All raul trillo Articles
-
510Latest Myopia NewsVyluma Receives EU Marketing Application Authorization for Low-Dose Atropine NVK002
May 29, 2024 BRIDGEWATER, N.J. — Vyluma announced it has received approval from the European Medicines Agency (EMA) of its Marketing Authorization...
-
1.6KLatest Myopia NewsGMAC Unveils 2023 Board Members
February 13, 2023 ST. LOUIS, Mo. — The Global Myopia Awareness Coalition (GMAC) announced its 2023 Board of Directors, including a new...
-
1.1KClinicalVyluma’s Navneet Puri and Raul Trillo Discuss CHAMP Study Results
sponsored content November 1, 2022 Review of Myopia Management’s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives...
-
3.2KClinicalVyluma CHAMP Pivotal Phase 3 Clinical Trial Q&A
sponsored content October 27, 2022 Vyluma aims to preserve the vision of a global population by providing meaningful and effective pharmaceutical ophthalmic...
-
1.9KLatest Myopia NewsVyluma and Laboratories Théa Enter Licensing Agreement for NVK002
June 14, 2022 BRIDGEWATER, N.J. — Vyluma and Laboratories Théa have entered into an exclusive licensing agreement for the registration and commercialization...
-
949Latest Myopia NewsGMAC Appoints 2022 Board Members
May 20, 2022 ST. LOUIS, Mo. — The Global Myopia Awareness Coalition (GMAC) announced the appointment of its Board for 2022, including...
-
3.2KLatest Myopia NewsGlobal Myopia Awareness Coalition Elects 2021 Board of Directors
January 28, 2021 ST. LOUIS, Mo. — The Global Myopia Awareness Coalition (GMAC) has named its 2021 Board of Directors. The new...
-
Various sizes are available on MyMopia.com for digital and print use.
Various sizes are available on MyMopia.com for digital and print use.5.8KLatest Myopia NewsMyMyopia Introduces Infographic for Easy Understanding of Myopia, its Impact, and Treatment Options
May 5, 2020 MyMyopia is a disease awareness effort that shares important information with parents and eye care professionals on the growing...
-
6.0KKey IssuesA Wake-up Call to the Long-term Threat of Myopia
Myopia progression is irreversible, so when this treatment window closes, the higher risk of vision loss remains for life.